Moving Forward: Pfizer and a group of researchers are waiting for permission to initiate a human study in the U.K. of a possible treatment for age-related macular degeneration that is derived from human embryonic stem cells, the WSJ reports. It’s a sign that research on the controversial cells is moving forward into actual clinical studies.
Off Limits: A new California law says that if you’re a teenager, tanning beds will be off limits starting Jan. 1 — even if you have permission from your parents, Reuters reports. Gov. Jerry Brown yesterday signed a law banning minors from using the beds.
No “Captive Supplier”: Novo Nordisk CEO Lars Rebien Sorensen defended his company’s 2010 stand-off with Greece over planned cuts to reimbursements for some insulin products, saying Novo couldn’t be a “captive supplier,” the WSJ reports. Novo and other pharma companies are facing tough negotiations over prices with cash-strapped governments, particularly in southern Europe.
How it Differs: Florida’s health insurance exchange, which is set to launch in early 2012, differs in key ways from those to be offered under the health-care overhaul law, Kaiser Health News reports. It will focus on small businesses and won’t allow individuals to participate, won’t require plans to have a package of essential benefits and won’t issue subsidies or tax credits to those purchasing coverage. In addition, there would be participation fees for plans and insurance agents that participate in the exchange, KHN says.
Reported by Katherine Hobson